The difference between what Afterpay offer the consumer market and what Cirralto is offering the business/commercial space is the software and the integration of that with the payment terms and credit access. Without the software it would be a hard sell as businesses have two main issues -debtors and their impact on cashflow and the resulting impact of that on time. From what I understand what we have here is a billing system that controls the flow of money and allows the creditor instant access to the funds whilst debtor gets the time it needs to pay. This is all controlled via the software. Xero is a success because it allowed businesses real time access to their pnl and balance sheet without the reliance on their accountant to process invoices, etc. It gave them back time. It could be the best innovation in cashflow management that we have seen for some time.
Whilst this still has a long way to go it is a massive step towards tidying up the biggest issue that companies face on a daily basis - collecting their money and enhancing their cashflow. As someone who used to look after commercial enterprises at a senior level this will likely remove the ongoing need for temporary overdraft facilities to facilitate cashflow, which in turn reduces fees as it costs the business every time they have one applied. That is one small thing that this should alleviate and I am sure there are many more.
I do feel there is decent potential with this one but you will need a little patience and we will need to see management cut out the suspensions from trading and tidy up their admin.
- Forums
- ASX - By Stock
- SPX
- it's just the beginning for Cirralto!
it's just the beginning for Cirralto!, page-3155
-
-
- There are more pages in this discussion • 17,191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.001(8.33%) |
Mkt cap ! $59.84M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.2¢ | $107.2K | 8.299M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 6076621 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1060960 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 6076621 | 0.012 |
19 | 9326754 | 0.011 |
11 | 5989666 | 0.010 |
9 | 2572222 | 0.009 |
9 | 17342500 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 903311 | 5 |
0.014 | 6320061 | 17 |
0.015 | 9164955 | 11 |
0.016 | 8440953 | 6 |
0.017 | 8642857 | 7 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online